1087 related articles for article (PubMed ID: 23519993)
1. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
2. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
3. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
[TBL] [Abstract][Full Text] [Related]
4. Identifying statin-associated autoimmune necrotizing myopathy.
Albayda J; Christopher-Stine L
Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of statin myopathy.
Mohassel P; Mammen AL
Curr Opin Rheumatol; 2013 Nov; 25(6):747-52. PubMed ID: 24061077
[TBL] [Abstract][Full Text] [Related]
7. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
Nichols L; Pfeifer K; Mammen AL; Shahnoor N; Konersman CG
J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481
[TBL] [Abstract][Full Text] [Related]
8. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
[TBL] [Abstract][Full Text] [Related]
9. Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy.
Floyd JS; Brody JA; Tiniakou E; Psaty BM; Mammen A
Muscle Nerve; 2016 Jun; 54(1):142-4. PubMed ID: 27038110
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated statin myopathy.
Loganathan P; Oddis CV; Aggarwal R
Expert Rev Clin Immunol; 2016; 12(1):33-8. PubMed ID: 26515829
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
12. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune myopathy associated with statin use].
Ljøstad U; Mygland Å
Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1360-2. PubMed ID: 27637055
[TBL] [Abstract][Full Text] [Related]
14. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced autoimmune necrotizing myopathy with pharyngeal muscles involvement.
Mirlesse N; Egervari K; Bornand A; Lecluse J; Lobrinus JA; Scheffler M; Serratrice C; Prendki V; Cuvelier C
Age Ageing; 2020 Aug; 49(5):883-884. PubMed ID: 32147707
[TBL] [Abstract][Full Text] [Related]
16. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
17. Statin induced necrotizing autoimmune myopathy.
Babu S; Li Y
J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
[TBL] [Abstract][Full Text] [Related]
18. Statin-Induced Autoimmune Necrotizing Myopathy.
Jayatilaka S; Desai K; Rijal S; Zimmerman D
J Prim Care Community Health; 2021; 12():21501327211028714. PubMed ID: 34219515
[TBL] [Abstract][Full Text] [Related]
19. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
[TBL] [Abstract][Full Text] [Related]
20. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
